Caplin Point Laboratories Limited (NSE:CAPLIPOINT)
India · Delayed Price · Currency is INR 2,138.40
+11.00 (0.52%)
Sep 3, 2025, 9:30 AM IST
Caplin Point Laboratories Market Cap
Caplin Point Laboratories has a market cap or net worth of 161.85 billion as of September 2, 2025. Its market cap has increased by 36.53% in one year.
Market Cap
161.85B
Enterprise Value
153.98B
Revenue
19.89B
Ranking
n/a
PE Ratio
28.64
Stock Price
2,138.40
Market Cap Chart
Since February 26, 2002, Caplin Point Laboratories's market cap has increased from 5.60M to 161.85B, an increase of 2,890,625.21%. That is a compound annual growth rate of 54.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2025 | 161.85B | -14.87% |
| Dec 31, 2024 | 190.12B | 84.60% |
| Dec 29, 2023 | 102.99B | 90.47% |
| Dec 30, 2022 | 54.07B | -16.82% |
| Dec 31, 2021 | 65.01B | 69.50% |
| Dec 31, 2020 | 38.35B | 68.44% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,825.74B |
| Divi's Laboratories | 1,627.72B |
| Cipla | 1,283.84B |
| Apollo Hospitals Enterprise | 1,094.20B |
| Mankind Pharma | 1,020.09B |
| Zydus Lifesciences | 987.17B |
| Fortis Healthcare | 688.14B |
| Alkem Laboratories | 634.11B |